Literature DB >> 1906395

Multiple forms of TGF-beta: distinct promoters and differential expression.

A B Roberts1, S J Kim, T Noma, A B Glick, R Lafyatis, R Lechleider, S B Jakowlew, A Geiser, M A O'Reilly, D Danielpour.   

Abstract

There are now five known distinct isoforms of TGF-beta with 64-82% identity. Of these, only TGF-beta 1, 2 and 3 thus far have been demonstrated to be expressed in mammalian tissues; TGF-beta 4 has been described only in chicken and TGF-beta 5 only in frog. Although the biological activities of these five isoforms of TGF-beta are indistinguishable in most in vitro assays their sites of synthesis and localization in vivo are often distinct. Expression of the various isoforms is differentially controlled both in vivo, as in development, and in vitro after treatment of cells with steroids, such as oestrogen or tamoxifen, or with retinoids. To investigate the basis of these observations we have cloned and characterized the promoters for the human TGF-beta 1, 2 and 3 genes. Significant differences have been found: whereas the TGF-beta 1 promoter has no TATAA box and is regulated principally by AP-1 sites, both the TGF-beta 2 and 3 promoters have TATAA boxes as well as AP-2 sites and cAMP-responsive elements. Accordingly, TGF-beta 1 gene expression is induced strongly by phorbol esters whereas that of TGF-beta 2 and 3 is induced by forskolin, an activator of adenylate cyclase. Expression of TGF-beta 2 and 3 is often coordinately regulated in vivo in a pattern distinct from that of TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906395     DOI: 10.1002/9780470514061.ch2

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  23 in total

1.  TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.

Authors:  Ashok Kumar; Ming Ruan; Kari Clifton; Farhan Syed; Sundeep Khosla; Merry Jo Oursler
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

Review 2.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

Review 3.  Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat.

Authors:  James V Falvo; Shahin Ranjbar; Luke D Jasenosky; Anne E Goldfeld
Journal:  Am J Respir Cell Mol Biol       Date:  2011-08-18       Impact factor: 6.914

Review 4.  Latency and activation in the control of TGF-beta.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

5.  Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.

Authors:  Syn Kok Yeo; Jian Wen; Song Chen; Jun-Lin Guan
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

6.  Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.

Authors:  Rance Nault; Kelly A Fader; Dustin A Ammendolia; Peter Dornbos; Dave Potter; Bonnie Sharratt; Kazuyoshi Kumagai; Jack R Harkema; Sophia Y Lunt; Jason Matthews; Tim Zacharewski
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

7.  Transforming growth factor beta 1 gene expression in human airways.

Authors:  J D Aubert; B I Dalal; T R Bai; C R Roberts; S Hayashi; J C Hogg
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

8.  Rho GTPase signaling promotes constitutive expression and release of TGF-β2 by human trabecular meshwork cells.

Authors:  Cynthia L Pervan; Jonathan D Lautz; Andrea L Blitzer; Kelly A Langert; Evan B Stubbs
Journal:  Exp Eye Res       Date:  2015-12-30       Impact factor: 3.467

9.  Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta.

Authors:  M D Botney; L Bahadori; L I Gold
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.

Authors:  L Rudnicka; J Varga; A M Christiano; R V Iozzo; S A Jimenez; J Uitto
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.